Цитирование
ALG-055009 in non-cirrhotic adults with metabolic dysfunction-associated steatohepatitis (HERALD): a randomised, double-blind, placebo-controlled, phase 2a trial. // The Lancet Gastroenterology & Hepatology. – URL: https://www.sciencedirect.com/science/article/pii/S2468125326001548?dgcid=rss_sd_all
ALG-055009 in non-cirrhotic adults with metabolic dysfunction-associated steatohepatitis (HERALD): a randomised, double-blind, placebo-controlled, phase 2a trial. The Lancet Gastroenterology & Hepatology. https://www.sciencedirect.com/science/article/pii/S2468125326001548?dgcid=rss_sd_all
“ALG-055009 in non-cirrhotic adults with metabolic dysfunction-associated steatohepatitis (HERALD): a randomised, double-blind, placebo-controlled, phase 2a trial.” The Lancet Gastroenterology & Hepatology.
@article{article68530,
title = {ALG-055009 in non-cirrhotic adults with metabolic dysfunction-associated steatohepatitis (HERALD): a randomised, double-blind, placebo-controlled, phase 2a trial},
journal = {The Lancet Gastroenterology \& Hepatology},
url = {https://www.sciencedirect.com/science/article/pii/S2468125326001548?dgcid=rss_sd_all}
}